Racial and Ethnic Differences in Antihypertensive Medication Use and Blood Pressure Control among US Adults with Hypertension: The National Health and Nutrition Examination Survey, 2003 to 2012

Circulation: Cardiovascular Quality and Outcomes

Volumn 10, Issue 1, 2017, Pages

  Gu, Anna ^a   Yue, Yu ^b   Desai, Raj P ^a   Argulian, Edgar ^c  

^a ST JOHN'S UNIVERSITY   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

blood pressure; cardiovascular diseases; drug therapy; hypertension; treatment outcome

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; THIAZIDE DIURETIC AGENT;

ADULT; AGE; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLACK PERSON; BLOOD PRESSURE REGULATION; CAUCASIAN; COMORBIDITY; CROSS-SECTIONAL STUDY; DIURETIC THERAPY; DRUG UTILIZATION; ETHNIC DIFFERENCE; FEMALE; HEALTH INSURANCE; HISPANIC; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICALLY UNINSURED; PRIORITY JOURNAL; RACE DIFFERENCE; UNITED STATES; ADOLESCENT; AFRICAN AMERICAN; BLOOD PRESSURE; CHI SQUARE DISTRIBUTION; CLINICAL PRACTICE; COMPARATIVE STUDY; DRUG EFFECTS; DRUG UTILIZATION REVIEW; EPIDEMIOLOGY; ETHNOLOGY; HEALTH CARE DISPARITY; HEALTH DISPARITY; INSURANCE; MIDDLE AGED; NUTRITION; ODDS RATIO; PATHOPHYSIOLOGY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; STATISTICAL MODEL; TREATMENT OUTCOME; TRENDS; YOUNG ADULT;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGE FACTORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION REVIEW; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH STATUS DISPARITIES; HEALTHCARE DISPARITIES; HISPANIC AMERICANS; HUMANS; HYPERTENSION; INSURANCE COVERAGE; INSURANCE, HEALTH; LINEAR MODELS; LOGISTIC MODELS; MALE; MEDICALLY UNINSURED; MIDDLE AGED; NUTRITION SURVEYS; ODDS RATIO; PRACTICE PATTERNS, PHYSICIANS'; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 85009944228     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.116.003166     Document Type: Article

References (44)

1. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010;303:2043-2050. doi: 10.1001/jama.2010.650
2. Gu Q, Burt VL, Dillon CF, Yoon S. Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health And Nutrition Examination Survey, 2001 to 2010. Circulation. 2012;126:2105-2114. doi: 10.1161/ CIRCULATIONAHA.112.096156
3. Sorlie PD, Allison MA, Avilés-Santa ML, Cai J, Daviglus ML, Howard AG, Kaplan R, Lavange LM, Raij L, Schneiderman N, Wassertheil-Smoller S, Talavera GA. Prevalence of hypertension, awareness, treatment, and control in the Hispanic Community Health Study/Study of Latinos. Am J Hypertens. 2014;27:793-800. doi: 10.1093/ajh/hpu003
4. McWilliams JM, Meara E, Zaslavsky AM, Ayanian JZ. Differences in control of cardiovascular disease and diabetes by race, ethnicity, and education: U.S trends from 1999 to 2006 and effects of Medicare coverage. Ann Intern Med. 2009; 21:505-515
5. Ayanian JZ, Landon BE, Newhouse JP, Zaslavsky AM. Racial and ethnic disparities among enrollees in Medicare Advantage plans. N Engl J Med. 2014;371:2288-2297. doi: 10.1056/NEJMsa1407273
6. Vulic D, Lee BT, Dede J, Lopez VA, Wong ND. Extent of control of cardiovascular risk factors and adherence to recommended therapies in US multiethnic adults with coronary heart disease: from a 2005-2006 national survey. Am J Cardiovasc Drugs. 2010;10:109-114. doi: 10.2165/11535240-000000000-00000
7. National Center for Health Statistics. Analytic and Reporting Guidelines: The National Health and Nutrition Examination Survey (NHANES). https:// www.cdc.gov/nchs/nhanes/survey-methods.htm. Accessed June 20, 2016
8. National Center for Health Statistics. NHANES Health Tech/Blood Pressure Procedures Manual. https://www.cdc.gov/nchs/data/nhanes/ nhanes-09-10/BP.pdf. Accessed June 18, 2016
9. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252. doi: 10.1161/01.HYP.0000107251.49515.c2
10. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC Jr, Svetkey LP, Taler SJ, Townsend RR, Wright JT Jr, Narva AS, Ortiz E. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507-520. doi: 10.1001/jama.2013.284427
11. Gregg EW, Cadwell BL, Cheng YJ, Cowie CC, Williams DE, Geiss L, Engelgau MM, Vinicor F. Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the U.S. Diabetes Care. 2004;27:2806-2812
12. American Diabetes Association. Standards of medical care in diabetes 2013. Diabetes Care. 2013; 36(suppl 1):S11-S66
13. National Center for Health Statistics NHANES 2005-2006. Documentation, Codebook, and Frequencies. Standard Biochemistry Profile. https://www.cdc.gov/Nchs/Nhanes/2005-2006/BIOPRO-D. htm#LBXSCR. Accessed May 16, 2016
14. Egan BM, Li J, Hutchison FN, Ferdinand KC. Hypertension in the United States, 1999 to 2012: progress toward Healthy People 2020 goals. Circulation. 2014;130:1692-1699. doi: 10.1161/ CIRCULATIONAHA.114.010676
15. Guo F, He D, Zhang W, Walton RG. Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010. J Am Coll Cardiol. 2012;60:599-606. doi: 10.1016/j. jacc.2012.04.026
16. Gu A, Yue Y, Argulian E. Age differences in treatment and control of hypertension in US physician offices, 2003-2010: a serial cross-sectional study. Am J Med. 2016;129:50-58.e4. doi: 10.1016/j.amjmed.2015.07.031
17. Shelley D, Tseng TY, Andrews H, Ravenell J, Wu D, Ferrari P, Cohen A, Millery M, Kopal H. Predictors of blood pressure control among hypertensives in community health centers. Am J Hypertens. 2011;24:1318-1323. doi: 10.1038/ajh.2011.154
18. Wang TJ, Vasan RS. Epidemiology of uncontrolled hypertension in the United States. Circulation. 2005;112:1651-1662. doi: 10.1161/ CIRCULATIONAHA.104.490599
19. Prugger C, Keil U, Wellmann J, de Bacquer D, de Backer G, Ambrosio GB, Reiner Z, Gaita D, Wood D, Kotseva K, Heidrich J; EUROASPIRE III Study Group. Blood pressure control and knowledge of target blood pressure in coronary patients across Europe: results from the EUROASPIRE III survey. J Hypertens. 2011;29:1641-1648. doi: 10.1097/ HJH.0b013e328348efa7
20. Yue Z, Bin W, Weilin Q, Aifang Y. Effect of medication adherence on blood pressure control and risk factors for antihypertensive medication adherence. J Eval Clin Pract. 2015;21:166-172. doi: 10.1111/jep.12268
21. Daugherty SL, Powers JD, Magid DJ, Masoudi FA, Margolis KL, O'Connor PJ, Schmittdiel JA, Ho PM. The association between medication adherence and treatment intensification with blood pressure control in resistant hypertension. Hypertension. 2012;60:303-309. doi: 10.1161/ HYPERTENSIONAHA.112.192096
22. Hendriks ME, Wit FW, Akande TM, Kramer B, Osagbemi GK, Tanovic Z, Gustafsson-Wright E, Brewster LM, Lange JM, Schultsz C. Effect of health insurance and facility quality improvement on blood pressure in adults with hypertension in Nigeria: a population-based study. JAMA Intern Med. 2014;174:555-563. doi: 10.1001/jamainternmed.2013.14458
23. Egan BM, Li J, Small J, Nietert PJ, Sinopoli A. The growing gap in hypertension control between insured and uninsured adults: National Health and Nutrition Examination Survey 1988 to 2010. Hypertension. 2014;64:997-1004. doi: 10.1161/HYPERTENSIONAHA.114.04276
24. Fuchs FD. Why do black Americans have higher prevalence of hypertension?: an enigma still unsolved. Hypertension. 2011;57:379-380. doi: 10.1161/HYPERTENSIONAHA.110.163196
25. Margolis KL, Piller LB, Ford CE, Henriquez MA, Cushman WC, Einhorn PT, Colon PJ, Vidt DG, Christian R, Wong ND, Wright JT Jr, Goff DC Jr; Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group. Blood pressure control in Hispanics in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Hypertension. 2007;50:854-861. doi: 10.1161/ HYPERTENSIONAHA.107.092650
26. Cooper-DeHoff RM, Aranda JM Jr, Gaxiola E, Cangiano JL, Garcia-Barreto D, Conti CR, Hewkin A, Pepine CJ; INVEST Investigators. Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients-findings from the International Verapamil SR/Trandolapril Study (INVEST). Am Heart J. 2006;151:1072-1079. doi: 10.1016/j.ahj.2005.05.024
27. Flack JM, Sica DA, Bakris G, Brown AL, Ferdinand KC, Grimm RH Jr, Hall WD, Jones WE, Kountz DS, Lea JP, Nasser S, Nesbitt SD, Saunders E, Scisney-Matlock M, Jamerson KA; International Society on Hypertension in Blacks. Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement. Hypertension. 2010;56:780-800. doi: 10.1161/ HYPERTENSIONAHA.110.152892
28. Ferdinand KC, Armani AM. The management of hypertension in African Americans. Crit Pathw Cardiol. 2007;6:67-71. doi: 10.1097/ HPC.0b013e318053da59
29. Harman J, Walker ER, Charbonneau V, Akylbekova EL, Nelson C, Wyatt SB. Treatment of hypertension among African Americans: the Jackson Heart Study. J Clin Hypertens (Greenwich). 2013;15:367-374. doi: 10.1111/jch.12088
30. Johnson JA. Ethnic differences in cardiovascular drug response: potential contribution of pharmacogenetics. Circulation. 2008;118:1383-1393. doi: 10.1161/CIRCULATIONAHA.107.704023
31. Sehgal AR. Overlap between whites and blacks in response to antihypertensive drugs. Hypertension. 2004;43:566-572. doi: 10.1161/01. HYP.0000118019.28487.9c
32. Burke GL, Savage PJ, Manolio TA, Sprafka JM, Wagenknecht LE, Sidney S, Perkins LL, Liu K, Jacobs DR Jr. Correlates of obesity in young black and white women: the CARDIA Study. Am J Public Health. 1992;82:1621-1625
33. Cohen SS, Matthews CE, Signorello LB, Schlundt DG, Blot WJ, Buchowski MS. Sedentary and physically active behavior patterns among low-income African-American and white adults living in the southeastern United States. PLoS One. 2013;8:e59975. doi: 10.1371/journal.pone.0059975
34. Traylor AH, Schmittdiel JA, Uratsu CS, Mangione CM, Subramanian U. Adherence to cardiovascular disease medications: does patient-provider race/ethnicity and language concordance matter? J Gen Intern Med. 2010;25:1172-1177. doi: 10.1007/s11606-010-1424-8
35. Redmond N, Baer HJ, Hicks LS. Health behaviors and racial disparity in blood pressure control in the national health and nutrition examination survey. Hypertension. 2011;57:383-389. doi: 10.1161/ HYPERTENSIONAHA.110.161950
36. Beach MC, Saha S, Korthuis PT, Sharp V, Cohn J, Wilson IB, Eggly S, Cooper LA, Roter D, Sankar A, Moore R. Patient-provider communication differs for black compared to white HIV-infected patients. AIDS Behav. 2011;15:805-811. doi: 10.1007/s10461-009-9664-5
37. Johnson RL, Roter D, Powe NR, Cooper LA. Patient race/ethnicity and quality of patient-physician communication during medical visits. Am J Public Health. 2004;94:2084-2090
38. Peterson ED, Gaziano JM, Greenland P. Recommendations for treating hypertension: what are the right goals and purposes? JAMA. 2014; 311:474-476
39. Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG, Flack JM, Carter BL, Materson BJ, Ram CV, Cohen DL, Cadet JC, Jean-Charles RR, Taler S, Kountz D, Townsend RR, Chalmers J, Ramirez AJ, Bakris GL, Wang J, Schutte AE, Bisognano JD, Touyz RM, Sica D, Harrap SB. Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens (Greenwich). 2014;16:14-26. doi: 10.1111/jch.12237
40. Touyz RM, Dominiczak AF. Hypertension Guidelines: Is It Time to Reappraise Blood Pressure Thresholds and Targets? Hypertension. 2016;67:688-689. doi: 10.1161/HYPERTENSIONAHA.116.07090
41. Dennison Himmelfarb CR, Hayman LL. Recent blood pressure guidelines: making sense of the controversy. J Cardiovasc Nurs. 2014;29:285-287. doi: 10.1097/JCN.0000000000000167
42. Wood S. "Hypertension debate continues, as JNC 8 'minority' speaks out", Heartwire from Medscape, 2014. https://www.medscape.com/viewarticle/ 819078. Accessed June 18, 2016
43. Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, Reboussin DM, Rahman M, Oparil S, Lewis CE, Kimmel PL, Johnson KC, Goff DC Jr, Fine LJ, Cutler JA, Cushman WC, Cheung AK, Ambrosius WT. The SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015; 373:2103-2116
44. Denker MG, Cohen DL. What is an appropriate blood pressure goal for the elderly: review of recent studies and practical recommendations. Clin Interv Aging. 2013;8:1505-1517. doi: 10.2147/CIA.S33087